XML 43 R33.htm IDEA: XBRL DOCUMENT
v3.22.1

Fair Value Measurement (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2022
Fair Value Disclosures [Abstract] |
Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis | The following table displays our assets and liabilities measured on our consolidated balance sheets at fair value on a recurring basis as of March 31, 2022 and December 31, 2021. Table 11.1: Assets and Liabilities Measured at Fair Value on a Recurring Basis
|  | March 31, 2022
|  | Fair Value Measurements Using |  | Netting Adjustments(1) |  |
(Dollars in millions) |  | Level 1 |  | Level 2 |  | Level 3 |  |  | Total
Assets: |  |  |  |  |  |  |  |  |  |
Securities available for sale: |  |  |  |  |  |  |  |  |  |
U.S. Treasury securities |  | $ | 9,497 |  |  | $ | 0 |  |  | $ | 0 |  |  | — |  |  | $ | 9,497 |
RMBS |  | 0 |  |  | 68,214 |  |  | 211 |  |  | — |  |  | 68,425 |
CMBS |  | 0 |  |  | 8,344 |  |  | 21 |  |  | — |  |  | 8,365 |
Other securities |  | 203 |  |  | 2,586 |  |  | 0 |  |  | — |  |  | 2,789 |
Total securities available for sale |  | 9,700 |  |  | 79,144 |  |  | 232 |  |  | — |  |  | 89,076 |
Loans held for sale |  | 0 |  |  | 928 |  |  | 0 |  |  | — |  |  | 928 |
Other assets: |  |  |  |  |  |  |  |  |  |
Derivative assets(2) |  | 1,106 |  |  | 3,211 |  |  | 202 |  |  | $ | (761) |  |  | 3,758 |
Other(3) |  | 525 |  |  | 4 |  |  | 39 |  |  | — |  |  | 568 |
Total assets |  | $ | 11,331 |  |  | $ | 83,287 |  |  | $ | 473 |  |  | $ | (761) |  |  | $ | 94,330 |
Liabilities: |  |  |  |  |  |  |  |  |  |
Other liabilities: |  |  |  |  |  |  |  |  |  |
Derivative liabilities(2) |  | $ | 2,225 |  |  | $ | 2,448 |  |  | $ | 180 |  |  | $ | (1,282) |  |  | $ | 3,571 |
Total liabilities |  | $ | 2,225 |  |  | $ | 2,448 |  |  | $ | 180 |  |  | $ | (1,282) |  |  | $ | 3,571 |
|  | December 31, 2021
|  | Fair Value Measurements Using |  | Netting Adjustments(1) |  |
(Dollars in millions) |  | Level 1 |  | Level 2 |  | Level 3 |  |  | Total
Assets: |  |  |  |  |  |  |  |  |  |
Securities available for sale: |  |  |  |  |  |  |  |  |  |
U.S. Treasury securities |  | $ | 9,442 |  |  | $ | 0 |  |  | $ | 0 |  |  | — |  |  | $ | 9,442 |
RMBS |  | 0 |  |  | 73,358 |  |  | 258 |  |  | — |  |  | 73,616 |
CMBS |  | 0 |  |  | 9,360 |  |  | 9 |  |  | — |  |  | 9,369 |
Other securities |  | 206 |  |  | 2,628 |  |  | 0 |  |  | — |  |  | 2,834 |
Total securities available for sale |  | 9,648 |  |  | 85,346 |  |  | 267 |  |  | — |  |  | 95,261 |
Loans held for sale |  | 0 |  |  | 1,026 |  |  | 0 |  |  | — |  |  | 1,026 |
Other assets: |  |  |  |  |  |  |  |  |  |
Derivative assets(2) |  | 406 |  |  | 2,200 |  |  | 84 |  |  | $ | (542) |  |  | 2,148 |
Other(3) |  | 526 |  |  | 6 |  |  | 41 |  |  | — |  |  | 573 |
Total assets |  | $ | 10,580 |  |  | $ | 88,578 |  |  | $ | 392 |  |  | $ | (542) |  |  | $ | 99,008 |
Liabilities: |  |  |  |  |  |  |  |  |  |
Other liabilities: |  |  |  |  |  |  |  |  |  |
Derivative liabilities(2) |  | $ | 838 |  |  | $ | 965 |  |  | $ | 65 |  |  | $ | (544) |  |  | $ | 1,324 |
Total liabilities |  | $ | 838 |  |  | $ | 965 |  |  | $ | 65 |  |  | $ | (544) |  |  | $ | 1,324 |
__________ (1)Represents balance sheet netting of derivative assets and liabilities, and related payables and receivables for cash collateral held or placed with the same counterparty. See “Note 8—Derivative Instruments and Hedging Activities” for additional information. (2)Does not reflect $10 million and $11 million recognized as a net valuation allowance on derivative assets and liabilities for non-performance risk as of March 31, 2022 and December 31, 2021, respectively. Non-performance risk is included in derivative assets and liabilities, which are part of other assets and other liabilities on the consolidated balance sheets, and is recorded through non-interest income in the consolidated statements of income. (3)As of March 31, 2022 and December 31, 2021, other includes retained interests in securitizations of $39 million and $41 million, deferred compensation plan assets of $494 million and $490 million, and equity securities of $35 million (including unrealized loss of $5 million) and $42 million (including unrealized loss of $36 million), respectively.
Schedule of Level 3 Inputs Reconciliation | The table below presents a reconciliation for all assets and liabilities measured and recognized at fair value on a recurring basis using significant unobservable inputs (Level 3) for the three months ended March 31, 2022 and 2021. Generally, transfers into Level 3 were primarily driven by the usage of unobservable assumptions in the pricing of these financial instruments as evidenced by wider pricing variations among pricing vendors and transfers out of Level 3 were primarily driven by the usage of assumptions corroborated by market observable information as evidenced by tighter pricing among multiple pricing sources. Table 11.2: Level 3 Recurring Fair Value Rollforward
|  | Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
|  | Three Months Ended March 31, 2022
|  |  |  | Total Gains (Losses) (Realized/Unrealized) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | Net Unrealized Gains (Losses) Included in Net Income Related to Assets and Liabilities Still Held as of March 31, 2022(1)
(Dollars in millions) |  | Balance, January 1, 2022 |  | Included in Net Income(1) |  | Included in OCI |  | Purchases |  | Sales |  | Issuances |  | Settlements |  | Transfers Into Level 3 |  | Transfers Out of Level 3 |  | Balance, March 31, 2022 |
Securities available for sale:(2) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
RMBS |  | $ | 258 |  |  | $ | 10 |  |  | $ | (12) |  |  | $ | 0 |  |  | $ | 0 |  |  | $ | 0 |  |  | $ | (28) |  |  | $ | 12 |  |  | $ | (29) |  |  | $ | 211 |  |  | $ | 3 |
CMBS |  | 9 |  |  | 0 |  |  | 0 |  |  | 0 |  |  | 0 |  |  | 0 |  |  | (1) |  |  | 13 |  |  | 0 |  |  | 21 |  |  | (1) |
Total securities available for sale |  | 267 |  |  | 10 |  |  | (12) |  |  | 0 |  |  | 0 |  |  | 0 |  |  | (29) |  |  | 25 |  |  | (29) |  |  | 232 |  |  | 2 |
Other assets: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Retained interests in securitizations |  | 41 |  |  | (2) |  |  | 0 |  |  | 0 |  |  | 0 |  |  | 0 |  |  | 0 |  |  | 0 |  |  | 0 |  |  | 39 |  |  | (2) |
Net derivative assets (liabilities)(3) |  | 19 |  |  | 5 |  |  | 0 |  |  | 0 |  |  | 0 |  |  | 28 |  |  | (2) |  |  | (28) |  |  | 0 |  |  | 22 |  |  | 1 |
|  | Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
|  | Three Months Ended March 31, 2021
|  |  |  | Total Gains (Losses) (Realized/Unrealized) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | Net Unrealized Gains (Losses) Included in Net Income Related to Assets and Liabilities Still Held as of March 31, 2021(1)
(Dollars in millions) |  | Balance, January 1, 2021 |  | Included in Net Income(1) |  | Included in OCI |  | Purchases |  | Sales |  | Issuances |  | Settlements |  | Transfers Into Level 3 |  | Transfers Out of Level 3 |  | Balance, March 31, 2021 |
Securities available for sale:(2) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
RMBS |  | $ | 328 |  |  | $ | 7 |  |  | $ | 2 |  |  | $ | 0 |  |  | $ | 0 |  |  | $ | 0 |  |  | $ | (26) |  |  | $ | 39 |  |  | $ | (24) |  |  | $ | 326 |  |  | $ | 7 |
CMBS |  | 111 |  |  | 0 |  |  | (2) |  |  | 0 |  |  | 0 |  |  | 0 |  |  | (6) |  |  | 0 |  |  | (93) |  |  | 10 |  |  | 0 |
Total securities available for sale |  | 439 |  |  | 7 |  |  | 0 |  |  | 0 |  |  | 0 |  |  | 0 |  |  | (32) |  |  | 39 |  |  | (117) |  |  | 336 |  |  | 7 |
Other assets: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Retained interests in securitizations |  | 55 |  |  | (5) |  |  | 0 |  |  | 0 |  |  | 0 |  |  | 0 |  |  | 0 |  |  | 0 |  |  | 0 |  |  | 50 |  |  | (5) |
Net derivative assets (liabilities)(3) |  | 31 |  |  | (21) |  |  | 0 |  |  | 0 |  |  | 0 |  |  | 38 |  |  | (14) |  |  | 0 |  |  | 0 |  |  | 34 |  |  | (19) |
__________ (1)Realized gains (losses) on securities available for sale are included in net securities gains (losses) and retained interests in securitizations are reported as a component of non-interest income in our consolidated statements of income. Gains (losses) on derivatives are included as a component of net interest income or non-interest income in our consolidated statements of income. (2)Net unrealized losses included in OCI related to Level 3 securities available for sale still held as of March 31, 2022 were $7 million. Net unrealized losses included in OCI related to Level 3 securities available for sale still held as of March 31, 2021 were $2 million. (3)Includes derivative assets and liabilities of $202 million and $180 million, respectively, as of March 31, 2022 and $157 million and $123 million, respectively, as of March 31, 2021.
Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis Quantitative Information | The following table presents the significant unobservable inputs used to determine the fair values of our Level 3 financial instruments on a recurring basis. We utilize multiple vendor pricing services to obtain fair value for our securities. Several of our vendor pricing services are only able to provide unobservable input information for a limited number of securities due to software licensing restrictions. Other vendor pricing services are able to provide unobservable input information for all securities for which they provide a valuation. As a result, the unobservable input information for the securities available for sale presented below represents a composite summary of all information we are able to obtain. The unobservable input information for all other Level 3 financial instruments is based on the assumptions used in our internal valuation models. Table 11.3: Quantitative Information about Level 3 Fair Value Measurements
|  | Quantitative Information about Level 3 Fair Value Measurements
(Dollars in millions) |  | Fair Value at March 31, 2022 |  | Significant Valuation Techniques |  | Significant Unobservable Inputs |  | Range |  | Weighted Average(1)
Securities available for sale: |  |  |  |  |  |  |  |  |  |
RMBS |  | $ | 211 |  |  | Discounted cash flows (vendor pricing) |  | Yield Voluntary prepayment rate Default rate Loss severity |  | 0-25% 5-20% 0-11% 30-88% |  | 4% 11% 2% 63%
CMBS |  | 21 |  |  | Discounted cash flows (vendor pricing) |  | Yield |  | 1-23% |  | 15%
Other assets: |  |  |  |  |  |  |  |  |  |
Retained interests in securitizations(2) |  | 39 |  |  | Discounted cash flows |  | Life of receivables (months) Voluntary prepayment rate Discount rate Default rate Loss severity |  | 29-37 9-18% 3-8% 1-3% 76-291% |  | N/A
Net derivative assets (liabilities) |  | 22 |  |  | Discounted cash flows |  | Swap rates |  | 2% |  | 2%
|  | Quantitative Information about Level 3 Fair Value Measurements
(Dollars in millions) |  | Fair Value at December 31, 2021 |  | Significant Valuation Techniques |  | Significant Unobservable Inputs |  | Range |  | Weighted Average(1)
Securities available for sale: |  |  |  |  |  |  |  |  |  |
RMBS |  | $ | 258 |  |  | Discounted cash flows (vendor pricing) |  | Yield Voluntary prepayment rate Default rate Loss severity |  | 0-21% 5-40% 1-11% 30-100% |  | 3% 11% 2% 65%
CMBS |  | 9 |  |  | Discounted cash flows (vendor pricing) |  | Yield |  | 1-2% |  | 1%
Other assets: |  |  |  |  |  |  |  |  |  |
Retained interests in securitizations(2) |  | 41 |  |  | Discounted cash flows |  | Life of receivables (months) Voluntary prepayment rate Discount rate Default rate Loss severity |  | 29-36 9-18% 2-8% 3-4% 72-151% |  | N/A
Net derivative assets (liabilities) |  | 19 |  |  | Discounted cash flows |  | Swap rates |  | 1-2% |  | 2%
__________ (1)Weighted averages are calculated by using the product of the input multiplied by the relative fair value of the instruments. (2)Due to the nature of the various mortgage securitization structures in which we have retained interests, it is not meaningful to present a consolidated weighted average for the significant unobservable inputs.
Schedule of Assets Measured at Fair Value on Nonrecurring Basis | The following table presents the carrying value of the assets measured at fair value on a nonrecurring basis and still held as of March 31, 2022 and December 31, 2021, and for which a nonrecurring fair value measurement was recorded during the three and twelve months then ended. Table 11.4: Nonrecurring Fair Value Measurements
|  | March 31, 2022
|  | Estimated Fair Value Hierarchy |  | Total
(Dollars in millions) |  | Level 2 |  | Level 3 |
Loans held for investment |  | $ | 0 |  |  | $ | 130 |  |  | $ | 130 |
Loans held for sale |  | 123 |  |  | 0 |  |  | 123 |
Other assets(1) |  | 0 |  |  | 45 |  |  | 45 |
Total |  | $ | 123 |  |  | $ | 175 |  |  | $ | 298 |
|  | December 31, 2021
|  | Estimated Fair Value Hierarchy |  | Total
(Dollars in millions) |  | Level 2 |  | Level 3 |
Loans held for investment |  | $ | 0 |  |  | $ | 194 |  |  | $ | 194 |
Loans held for sale |  | 118 |  |  | 0 |  |  | 118 |
Other assets(1) |  | 0 |  |  | 325 |  |  | 325 |
Total |  | $ | 118 |  |  | $ | 519 |  |  | $ | 637 |
__________ (1)As of March 31, 2022, other assets included repossessed assets of $45 million. As of December 31, 2021, other assets included equity method investments of $50 million, investments accounted for under measurement alternative of $29 million, repossessed assets of $40 million and long-lived assets held for sale of $206 million.
Schedule of Earnings Related to Assets Measured at Fair Value on Nonrecurring Basis | The following table presents total nonrecurring fair value measurements for the period, included in earnings, attributable to the change in fair value relating to assets that are still held at March 31, 2022 and 2021. Table 11.5: Nonrecurring Fair Value Measurements Included in Earnings
|  | Total Gains (Losses)
|  | Three Months Ended March 31,
(Dollars in millions) |  | 2022 |  | 2021
Loans held for investment |  | $ | (14) |  |  | $ | (16) |
Other assets(1) |  | (19) |  |  | (36) |
Total |  | $ | (33) |  |  | $ | (52) |
__________ (1)Other assets include fair value adjustments related to repossessed assets, long-lived assets held for sale and equity investments accounted for under the measurement alternative.
Schedule of Fair Value of Financial Instruments | The following table presents the carrying value and estimated fair value, including the level within the fair value hierarchy, of our financial instruments that are not measured at fair value on a recurring basis on our consolidated balance sheets as of March 31, 2022 and December 31, 2021. Table 11.6: Fair Value of Financial Instruments
|  | March 31, 2022
|  | Carrying Value |  | Estimated Fair Value |  | Estimated Fair Value Hierarchy
(Dollars in millions) |  |  |  | Level 1 |  | Level 2 |  | Level 3
Financial assets: |  |  |  |  |  |  |  |  |  |
Cash and cash equivalents |  | $ | 26,804 |  |  | $ | 26,804 |  |  | $ | 5,107 |  |  | $ | 21,697 |  |  | $ | 0 |
Restricted cash for securitization investors |  | 281 |  |  | 281 |  |  | 281 |  |  | 0 |  |  | 0 |
Net loans held for investment |  | 269,158 |  |  | 273,434 |  |  | 0 |  |  | 0 |  |  | 273,434 |
Loans held for sale |  | 227 |  |  | 227 |  |  | 0 |  |  | 227 |  |  | 0 |
Interest receivable |  | 1,479 |  |  | 1,479 |  |  | 0 |  |  | 1,479 |  |  | 0 |
Other investments(1) |  | 1,492 |  |  | 1,492 |  |  | 0 |  |  | 1,492 |  |  | 0 |
Financial liabilities: |  |  |  |  |  |  |  |  |  |
Deposits with defined maturities |  | 17,306 |  |  | 17,218 |  |  | 0 |  |  | 17,218 |  |  | 0 |
Securitized debt obligations |  | 13,740 |  |  | 13,773 |  |  | 0 |  |  | 13,773 |  |  | 0 |
Senior and subordinated notes |  | 26,976 |  |  | 27,234 |  |  | 0 |  |  | 27,234 |  |  | 0 |
Federal funds purchased and securities loaned or sold under agreements to repurchase |  | 594 |  |  | 594 |  |  | 0 |  |  | 594 |  |  | 0 |
Other borrowings(2) |  | 4,000 |  |  | 4,000 |  |  | 0 |  |  | 4,000 |  |  | 0 |
Interest payable |  | 261 |  |  | 261 |  |  | 0 |  |  | 261 |  |  | 0 |
|  | December 31, 2021
|  | Carrying Value |  | Estimated Fair Value |  | Estimated Fair Value Hierarchy
(Dollars in millions) |  |  |  | Level 1 |  | Level 2 |  | Level 3
Financial assets: |  |  |  |  |  |  |  |  |  |
Cash and cash equivalents |  | $ | 21,746 |  |  | $ | 21,746 |  |  | $ | 4,164 |  |  | $ | 17,582 |  |  | $ | 0 |
Restricted cash for securitization investors |  | 308 |  |  | 308 |  |  | 308 |  |  | 0 |  |  | 0 |
Net loans held for investment |  | 265,910 |  |  | 270,508 |  |  | 0 |  |  | 0 |  |  | 270,508 |
Loans held for sale |  | 4,862 |  |  | 5,091 |  |  | 0 |  |  | 5,091 |  |  | 0 |
Interest receivable |  | 1,460 |  |  | 1,460 |  |  | 0 |  |  | 1,460 |  |  | 0 |
Other investments(1) |  | 1,344 |  |  | 1,344 |  |  | 0 |  |  | 1,344 |  |  | 0 |
Financial liabilities: |  |  |  |  |  |  |  |  |  |
Deposits with defined maturities |  | 17,923 |  |  | 18,062 |  |  | 0 |  |  | 18,062 |  |  | 0 |
Securitized debt obligations |  | 14,994 |  |  | 15,122 |  |  | 0 |  |  | 15,122 |  |  | 0 |
Senior and subordinated notes |  | 27,219 |  |  | 27,842 |  |  | 0 |  |  | 27,842 |  |  | 0 |
Federal funds purchased and securities loaned or sold under agreements to repurchase |  | 820 |  |  | 820 |  |  | 0 |  |  | 820 |  |  | 0 |
Interest payable |  | 281 |  |  | 281 |  |  | 0 |  |  | 281 |  |  | 0 |
__________ (1)Other investments include FHLB and Federal Reserve stock. These investments are included in other assets on our consolidated balance sheets. (2)Other borrowings exclude capital lease obligations.

X
- Definition Fair Value Assets Measured On Non Recurring Basis Gain Loss Included In Earnings [Table Text Block] + References No definition available. + Details
Name: | cof_FairValueAssetsMeasuredOnNonRecurringBasisGainLossIncludedInEarningsTableTextBlock
Namespace Prefix: | cof_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (bbb) -URI http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258 + Details
Name: | us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of assets and liabilities by class, including financial instruments measured at fair value that are classified in shareholders' equity, if any, that are measured at fair value on a nonrecurring basis in periods after initial recognition (for example, impaired assets). Disclosures may include, but are not limited to: (a) the fair value measurements recorded and the reasons for the measurements and (b) the level within the fair value hierarchy in which the fair value measurements are categorized in their entirety (levels 1, 2, 3). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (bbb) -URI http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258 + Details
Name: | us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258 + Details
Name: | us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 11 -URI http://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258 + Details
Name: | us-gaap_FairValueByBalanceSheetGroupingTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258 + Details
Name: | us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration